Zgradba BIBLIOGRAFSKE BAZE

1
ZgradbaBIBLIOGRAFSKE BAZE
2
Baza podatkov

• Baza podatkov ( podatkovna zbirka) zbirka
  informacij z dolocenega podrocja, ki so
  spravljene na dolocenem prostoru (Newlin, B.,
  1985).
• Ce so informacije spravljene na elektronski nacin
  racunalniko citljive baze podatkov.
• Online baze podatkov organizirane zbirke
  informacij, ki so dosegljive na elektronski nacin
  s pomocjo racunalnika, ki je lociran na vecji
  razdalji (Bjelland, H., 1992).

3
RAVNI PROCESIRANJA INFORMACIJ
TRADICIONALNI VIRI INFORMACIJ
INFORMACIJSKA PIRAMIDA
4
Bibliografske baze podatkov

• Bibliografski del
• Kljucne besede
• Abstrakt (izvlecek) ali polni tekst

5
(No Transcript)
6
BIBLIOGRAFSKA BAZAZNACILNA POLJA V ZAPISU

• DOCUMENT TYPE - DT (tip dokumenta) journal,
  book, standard, conference proceedings,
  commercial publication, technical report,
  dissertation
• AUTHORS AU (avtorji) imena avtorjev
• DOCUMENT TITLE TI (naslov dokumenta) naslov
  clanka, poglavja v knjigi
• CORPORATE SOURCE - CS (ustanova) ustanova, kjer
  so zaposleni avtorji
• LOCATION - LO lokacija institucije (mesto,
  drava)

7
BIBLIOGRAFSKA BAZAZNACILNA POLJA V ZAPISU

• SOURCE - SO (vir dokumenta ) ime revije, vol.,
  no., pp. ali ime knjige, zaloba, kraj, pp.
• PUBLICATION YEAR - PY (leto objave) leto objave
  publikacije
• LANGUAGE LA (jezik) jezik primarnega
  dokumenta (npr. ENG, GER, FRE, SLV)
• KEY WORDS - KW kljucne besede
• ABSTRACT AB povzetek

8
ZA PATENTE E

• PATENT NUMBER PN (patentna tevilka) tevilka
  patenta
• PUBLICATION DATE PD datum objave patenta
• PATENT APPLICATION AP (aplikacijska tevilka)
  tevilka patentne aplikacije
• PATENT APPLICATION DATE AD datum patentne
  aplikacije
• INTERNATIONAL CLASSIFICATION IC mednarodna
  patentna klasifikacija

9
Kljucne besede od splonega proti
specificnemu strukturirane skupine
PRIMER BIBLIOGRAFSKEGA ZAPISA za clanek iz revije
10
Kljucne besede nivojsko
PRIMER BIBLIOGRAFSKEGA ZAPISA za clanek iz revije
11
Kljucne besede nivojsko
PRIMER BIBLIOGRAFSKEGA ZAPISA za poglavje iz
knjige
12
Kljucne besede nivojsko
PRIMER BIBLIOGRAFSKEGA ZAPISA za prispevek s
konference
13
Kljucne besede od splonega proti
specificnemu strukturirane skupine
PRIMER BIBLIOGRAFSKEGA ZAPISA za patent
14
Kljucne besede nivojsko
PRIMER BIBLIOGRAFSKEGA ZAPISA za patent
15
PRIMER BIBLIOGRAFSKEGA ZAPISA za trno
publikacijo
16
Kljucne besede od splonega proti specificnemu
PRIMER BIBLIOGRAFSKEGA ZAPISA za standard
17
PRIMER BIBLIOGRAFSKEGA ZAPISA iz bibliografske
baze Web of Science
18
PRIMER BIBLIOGRAFSKEGA ZAPISA iz bibliografske
baze CAPlus za clanek http//stnweb.cas.org/
19
PRIMER BIBLIO. ZAPISA iz baze CAPlus za patent
20
PRIMER BIBLIOGRAFSKEGA ZAPISA iz bibliografske
baze COBIB http//www.cobiss.si/
21
ISKANJE PO

• tipu publikacije
• avtorjih
• intituciji avtorjev
• imenu revije ali knjige
• tevilki patenta
• tevilkah patentnih aplikacij
• mednarodni patentni klasifikaciji
• letnici objave publikacije
• jeziku
• kljucnih besedah

22
ISKANJE S KLJUCNIMI BESEDAMI

• po vsaki besedi posebej (word indexing, free-text
  indexing) npr. pressure AND sensitive AND
  copying AND paper
• po nizu besed, ki sestavljajo kljucno besedo -
  frazo (phrase indexing) npr. pressure sensitive
  copying paper
• oboje (phrase word indexing)

23
PRIPRAVA KLJUCNIH BESED

• kot tece tematika
• nivojsko
• od splonega proti specificnemu
• strukturirane skupine

24
PRIPRAVA POVZETKOV - ABSTRAKTOV
25
PRIMER POVZETKA
26
PRIMER POVZETKA
27
PRIMER POVZETKA
28
PRIMER POVZETKA
29
Primer povzetka patenta (EPO)

• Abstract of JP6312934PURPOSE To obtain an
  immunosuppressive agent, i.e. a substance having
  an excellent immunosuppressive effect by
  extracting mycelia or fruit bodies of MAITAKE (a
  kind of mushrooms which belongs to Grifola).
  CONSTITUTION Mycelia or fruit bodies of MAITAKE
  are treated with hot water to obtain a soluble
  fraction. Alcohol is added to the extract and the
  fraction in the alcohol solution is collected
  after standing for a given hours. The fraction is
  then dissolved in water to obtain a material
  having an immunosuppressive effect. The material
  is immunosuppressive, i.e. activities of
  suppresser T cells are activated and inhibition
  of cancer immunoactivity is expressed.

30
Primer povzetka iz baze Medline

• ICR mice were treated with a carcinogen,
  N-butyl-N'-butanolnitrosoamine BBN), every day
  for 8 consecutive weeks and the effects of oral
  administration of edible mushrooms on the
  induction of urinary bladder carcinoma and on the
  activities of macrophages and lymphocytes were
  studied. Bladder carcinoma were found in all 10
  mice (100) treated with BBN alone, while we
  observed carcinoma only in 9 of 17 mice (52.9),
  in 7 of 15 mice (46.7) and 13 of 20 mice (65.0)
  treated with Lentinus edodes, Grifola frondosa
  and Pleurotus ostreatus, respectively.
  Chemotactic activity of macrophages was
  suppressed in mice treated with BBN alone but
  maintained almost the normal level in mice
  treated with BBN plus Lentinus, Grifola or
  Pleurotus. Lymphocytes collected from mice
  treated with BBN plus each mushroom showed almost
  normal blastogenic response against concanavalin
  A, although those from mice treated with BBN
  alone completely retarded their response.
  Cytotoxic activity of lymphocytes against Yac-1
  cells was also maintained at a normal level in
  mice treated with BBN plus each mushroom. Whereas
  in mice treated with BBN alone significant
  depression of NK cell activity occurred.
  Significantly higher cytotoxic activity against
  P-815 cells was observed in lymphocytes from mice
  treated with BBN plus each mushroom than that in
  lymphocytes from normal mice or mice treated with
  BBN alone.

31
Primer povzetka iz J. Cancer Research

• Objective To improve the poor efficacy (lt 10)
  of chemotherapy for patients with
  hormone-refractory prostate cancer, we
  investigated a possible cytotoxic effect of
  carmustine/-glucan combination on prostatic
  cancer PC-3 cells, focusing on a
  glutathione-dependent detoxifying enzyme,
  glyoxalase I (Gly-I).
• Methods Carmustine (BCNU) is an anticancer agent
  and a putative inhibitor of Gly-I, while -glucan
  is a unique, nontoxic polysaccharide extracted
  from maitake mushrooms. The cytotoxic effects of
  BCNU or other anticancer agents with -glucan on
  PC-3 cells were assessed by cell-viability
  testing and Gly-I activity was measured using the
  spectrophotometric method.
• Results BCNU, 5-fluorouracil (5-FU), and
  methotrexate (MTX) were capable of inducing
  approximately a 50 reduction in cell viability
  at 72 hours, while etoposide, cisplatin, and
  mitomycin C were all ineffective. Only the
  combination of BCNU (50 mol) and -glucan (60
  g/mL) exhibited an enhanced cytotoxicity with an
  approximate 90 cell viability reduction, but
  little improvement was seen with any combinations
  of 5-FU, MTX, or -glucon. Gly-I assays revealed
  that such a profound (90) cell death was
  accompanied by an approximate 80 reduction in
  Gly-I activity by 6 hours.
• Conclusion This study demonstrates a sensitized
  cytotoxic effect of BCNU with -glucan in PC-3
  cells, which was associated with a drastic (80)
  inactivation of Gly-I. Therefore, the
  BCNU/-glucan combination may help to improve
  current treatment efficacy by targeting Gly-I,
  which appears to be critically involved in
  prostate cancer viability.

32
PRIMER PRIPRAVE VHODNEGA DOKUMENTA ZA
CLANEK DC primary DT journal AU Anelj,
M. TI Verigol Bio - do okolja prijazno
olje DS Sodobno kmetijstvo, 1995, Vol. 28, No.2,
pp. 90-91 PY 1995 LA SLV KW ekologija ecolog
y onesnaevanje voda water pollution varstvo
okolja environmental protection strojna
olja machine oils mazivna olja lubricating
oils sinteticni estri synthetic esters
nadaljevanje..
33
.. nadaljevanje
polialkilen glikoli polyalkylene
glycols rastlinska olja plant oils bioloko
razgradljiva olja biologically degradable
oils zakonodaja legislation slovenski
standard Slovenian standard trni
proizvod commercial product okolju prijazno
olje za age environmentally friendly saw
oils Verigol Bio Verigol Bio repicno
olje rapeseed oil dodatki additives stabiliza
cija stabilisation oksidacijska
sposobnost oxydative capacity proizvajalci produ
cers Petrol Petrol Mercator Oljarna Mercator
Oljarna testiranje testing uporaba use lastnos
ti properties
34
(No Transcript)
35
DOBRO ZASNOVANA BIBLIOGRAFSKA BAZA UPORABNIKU
ZAGOTAVLJA

• urejen pregled nad zbrano literaturo
• hitro iskanje in izbor najustreznejih dokumentov
• zanesljivo preverjanje podatkov
• ucinkovito obdelavo podatkov in pripravo
  sortiranih izpisov
• bolji pregled nad irim podrocjem dela
• sprotno spremljanje novosti, zasledovanje trendov

36
GRADNJA BIBLIOGRAFSKE BAZE

• analiza literature, grupiranje podobnih
  dokumentov
• opredelitev vsebine s kljucnimi besedami (in
  povzetki)
• primerjava, usklajevanje, poenotenje,
  lektoriranje kljucnih besed (in povzetkov)
• priprava vhodnih dokumentov, vnos podatkov v
  racunalnik
• pregledni izpisi, kontrola, vnos popravkov

37
Prednosti specializiranih in-house bibliografskih
baz pred mednarodnimi trno dostopnimi bazami

• globlje in bolj strukturirano postavljanje
  kljucnih besed (kvalitetneje iskanje)
• investicija v gradnjo, procesiranje pa je
  brezplacno (redna uporaba baze)

38
Gradnja lastne specializirane bibiografske baze
je smiselna (se obrestuje) ce

• ima uporabnik trajneji interes
• je tevilo publikacij veliko
• je zagotovljeno sprotno dograjevanje baze

39
Smeri razvoja

• Povezovanje vec sorodnih bilbiografskih baz
  (skupni iskalniki)
• Monost neposrednega narocanja primarnih virov
• Neposredne povezave sekundarnih dokumentov s
  primarnimi viri (.pdf)
• Neposredne HTML povezave referenc v besedilu s
  primarnimi viri v elektronski obliki